re: Ann: GoldStone Homase/Akrokerri Resources... seems like sellers are gone the share price should recover to 13 i would say .Littlecorn knows nothing i would say
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%